(COCO) Vita Coco - Ratings and Ratios
Coconut Water, Coconut Oil, Coconut Milk, Protein Drink, Packaged Water
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 40.7% |
| Value at Risk 5%th | 61.4% |
| Relative Tail Risk | -8.22% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.97 |
| Alpha | 31.93 |
| CAGR/Max DD | 1.49 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.539 |
| Beta | 0.749 |
| Beta Downside | 0.579 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.55% |
| Mean DD | 11.02% |
| Median DD | 9.62% |
Description: COCO Vita Coco November 11, 2025
The Vita Coco Company Inc. (NASDAQ: COCO) manufactures, markets, and distributes a portfolio of coconut-based beverages-including coconut water, coconut oil, coconut juice, coconut milk, and a protein-infused fitness drink (PWR LIFT)-under the Vita Coco brand, plus packaged water under the Ever & Ever label and private-label offerings for retailers.
Its products reach consumers across North America, Europe, the Middle East, Africa, and the Asia-Pacific through a diversified channel mix: club stores, food and drug retailers, mass-market and convenience outlets, e-commerce platforms, and food-service accounts.
Key recent metrics (FY 2023): revenue of approximately $1.2 billion, up roughly 12 % year-over-year, driven by a 15 % increase in volume sales of coconut water and a 9 % rise in average selling price (ASP) from premium-positioning. The company reported an adjusted EBITDA margin of ~ 8 %, reflecting ongoing cost-control initiatives in sourcing and logistics.
Sector drivers that materially affect COCO include the global coconut water market’s projected CAGR of 9 % through 2028, rising consumer demand for functional and low-sugar beverages, and supply-chain sensitivity to tropical weather events that can impact raw-material availability and cost.
For a deeper quantitative dive, the ValueRay platform provides granular financial metrics and peer comparisons that can help assess COCO’s valuation relative to its growth trajectory.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (69.2m TTM) > 0 and > 6% of Revenue (6% = 36.6m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA -8.97pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 49.22% (prev 46.49%; Δ 2.73pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 58.0m <= Net Income 69.2m (YES >=105%, WARN >=100%) |
| Net Debt (-189.7m) to EBITDA (80.2m) ratio: -2.36 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.43 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (59.9m) change vs 12m ago 0.95% (target <= -2.0% for YES) |
| Gross Margin 36.00% (prev 39.80%; Δ -3.80pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 149.6% (prev 140.1%; Δ 9.49pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -14.47 (EBITDA TTM 80.2m / Interest Expense TTM -5.49m) >= 6 (WARN >= 3) |
Altman Z'' 8.85
| (A) 0.65 = (Total Current Assets 423.3m - Total Current Liabilities 123.5m) / Total Assets 461.3m |
| (B) 0.48 = Retained Earnings (Balance) 222.5m / Total Assets 461.3m |
| (C) 0.19 = EBIT TTM 79.4m / Avg Total Assets 407.2m |
| (D) 1.63 = Book Value of Equity 223.7m / Total Liabilities 137.6m |
| Total Rating: 8.85 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 81.06
| 1. Piotroski 3.50pt |
| 2. FCF Yield 1.90% |
| 3. FCF Margin 8.69% |
| 4. Debt/Equity 0.04 |
| 5. Debt/Ebitda -2.36 |
| 6. ROIC - WACC (= 12.73)% |
| 7. RoE 23.90% |
| 8. Rev. Trend 78.47% |
| 9. EPS Trend 81.20% |
What is the price of COCO shares?
Over the past week, the price has changed by -3.41%, over one month by +12.64%, over three months by +33.67% and over the past year by +47.09%.
Is COCO a buy, sell or hold?
- Strong Buy: 4
- Buy: 1
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the COCO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 55.4 | 5.6% |
| Analysts Target Price | 55.4 | 5.6% |
| ValueRay Target Price | 74 | 41% |
COCO Fundamental Data Overview December 18, 2025
P/E Trailing = 45.4
P/E Forward = 28.8184
P/S = 4.8799
P/B = 9.501
Beta = 0.366
Revenue TTM = 609.3m USD
EBIT TTM = 79.4m USD
EBITDA TTM = 80.2m USD
Long Term Debt = 3000 USD (from longTermDebt, last fiscal year)
Short Term Debt = 5000 USD (from shortTermDebt, last quarter)
Debt = 14.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -189.7m USD (from netDebt column, last quarter)
Enterprise Value = 2.78b USD (2.97b + Debt 14.0m - CCE 203.7m)
Interest Coverage Ratio = -14.47 (Ebit TTM 79.4m / Interest Expense TTM -5.49m)
FCF Yield = 1.90% (FCF TTM 52.9m / Enterprise Value 2.78b)
FCF Margin = 8.69% (FCF TTM 52.9m / Revenue TTM 609.3m)
Net Margin = 11.35% (Net Income TTM 69.2m / Revenue TTM 609.3m)
Gross Margin = 36.00% ((Revenue TTM 609.3m - Cost of Revenue TTM 390.0m) / Revenue TTM)
Gross Margin QoQ = 37.66% (prev 36.30%)
Tobins Q-Ratio = 6.03 (Enterprise Value 2.78b / Total Assets 461.3m)
Interest Expense / Debt = -39.15% (Interest Expense -5.49m / Debt 14.0m)
Taxrate = 21.76% (6.68m / 30.7m)
NOPAT = 62.1m (EBIT 79.4m * (1 - 21.76%))
Current Ratio = 3.43 (Total Current Assets 423.3m / Total Current Liabilities 123.5m)
Debt / Equity = 0.04 (Debt 14.0m / totalStockholderEquity, last quarter 323.7m)
Debt / EBITDA = -2.36 (Net Debt -189.7m / EBITDA 80.2m)
Debt / FCF = -3.58 (Net Debt -189.7m / FCF TTM 52.9m)
Total Stockholder Equity = 289.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.99% (Net Income 69.2m / Total Assets 461.3m)
RoE = 23.90% (Net Income TTM 69.2m / Total Stockholder Equity 289.3m)
RoCE = 27.43% (EBIT 79.4m / Capital Employed (Equity 289.3m + L.T.Debt 3000 ))
RoIC = 21.46% (NOPAT 62.1m / Invested Capital 289.3m)
WACC = 8.74% (E(2.97b)/V(2.99b) * Re(8.78%) + (debt cost/tax rate unavailable))
Discount Rate = 8.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.32%
[DCF Debug] Terminal Value 67.19% ; FCFE base≈60.7m ; Y1≈39.8m ; Y5≈18.2m
Fair Price DCF = 5.57 (DCF Value 317.1m / Shares Outstanding 56.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 81.20 | EPS CAGR: 138.1% | SUE: 3.50 | # QB: 1
Revenue Correlation: 78.47 | Revenue CAGR: 21.96% | SUE: 4.0 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.33 | Chg30d=-0.015 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=1.63 | Chg30d=+0.247 | Revisions Net=+3 | Growth EPS=+38.8% | Growth Revenue=+13.7%
Additional Sources for COCO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle